logo
Karma Automotive solidifies lineup with focus on energy range-extended powertrains

Karma Automotive solidifies lineup with focus on energy range-extended powertrains

Yahoo31-03-2025
IRVINE, Calif. — In November 2023, Karma Automotive introduced the Kaveya coupe, a sleek electric vehicle pitched as the brand's halo model, launching an ambitious quest to go upmarket as an ultraluxury brand along with plans for a reimagined product portfolio.
In the 16 months since, the Southern California company, which dates to 2014 when Chinese auto parts maker Wanxiang Group acquired some of the assets of bankrupt Fisker Automotive, has built out its future product lineup with three new nameplates, while shifting its focus from EVs to energy range-extended powertrains.
And while the electric Kaveya remains in Karma's plans — the automaker said it'll launch in 2027 instead of 2026 — the brand is ready to execute, said Marques McCammon, the company's president.
Want to keep up with the latest product planning news? Go to Automotive News' regularly updated database of product plans for brands that sell in the United States. Future Product Pipeline >5-year product timelines by brand >
'Everything right now is about what we do and what we deliver,' McCammon told a crowd inside the company's headquarters here on March 20.
Karma, which McCammon likened to a grown-up startup during the presentation, took a pivotal step in late 2024 when it resumed output of the updated Revero sedan, an extended-range vehicle, at the automaker's Moreno Valley, Calif.
Karma is now shipping about four Reveros a week out of the plant, McCammon told journalists, and should sell around 250 new vehicles in 2025. Pricing for the Revero sedan starts at $125,600 including shipping. Production of the Invictus, based on the Revero, is set to begin in the second quarter. The performance variant features carbon-fiber body panels, chassis upgrades and aluminum wheels. Pricing starts at $187,500 including shipping.
The Gyesera sedan, first pitched as an EV, will now arrive as an extended-range vehicle, in the fourth quarter. It will be the Revero's successor. Karma said the change was in response to near-term market demand for EVs, which has softened.
The Amaris coupe, which debuted March 20, will arrive in 2026. The Karma lineup will be rounded out by the Ivara crossover in 2028. Both the Amaris and the Ivara will have energy range-extended powertrains.
The Ivara, which would be the automaker's first entry in the high-volume crossover segment, is critical to Karma's financial outlook.
'Our profitability is tied to Ivara, so 2028, 2029 is when we expect the business to be profitable,' McCammon said
He said Karma's ownership remains committed to the brand and noted he meets with the board quarterly. McCammon said he's made it clear to the board that Karma will attract new capital and financial support from U.S. investors but declined to specify beyond equity markets.
Sign up for the Automotive News Cars & Concepts newsletter, a weekly roundup of new and future product, design and auto show news.
The Revero, with roots dating to the 2011 Fisker Karma, features a 28-kilowatt-hour battery pack along with a 1.5-liter turbocharged engine mated to an onboard generator for a total of 536 hp and 550 pound-feet of torque. It has an electric-only range of 80 miles and a total range of 360 miles.
While details about the Amaris' powertrain and range have not been released, Karma said the coupe will use a turbocharged, four-cylinder engine as a generator.
Ed Kim, chief analyst at automotive research firm AutoPacific, said Karma has an opportunity to use its energy range-extended powertrain knowledge to gain an advantage.
The powertrain was ignored for a long time, Kim said, but that's changing with high-profile use cases such as the Ram 1500 Ramcharger and Scout Motors' Harvester extended-range EV energy system.
'All of a sudden, it's super relevant and they [Karma] happen to have it,' Kim said of the energy range-extended setup. 'That is their powertrain.'
But how well-heeled consumers will respond to Karma remains to be seen. And Karma's product rollout is taking place just as a trade war unfolds and threatens to drive new-vehicle prices higher. Karma could see some impact despite its vehicles being built in the U.S.
Analysts believe some exotic brands will be able to absorb the impact of U.S. auto tariffs because their customers often aren't deterred by higher prices.
McCammon said if Karma were to raise prices to mitigate the impact of any tariffs, customers would generally be less sensitive to such changes but acknowledged the brand doesn't enjoy the legacy or history of some competitors, which means Karma models need to be a relative value proposition.
McCammon is positioning Karma to be an ultraluxury U.S. brand and said it's an opportunity to return to a time 'where American ingenuity reigned atop the most prominent brands in the world,' pointing to Packard, Duesenberg, Cord and Auburn.
Karma customers, who McCammon said are typically entrepreneurs or business owners, are familiar with established ultraluxury and luxury brands. A Karma might be a third, fourth or fifth vehicle in someone's fleet, he noted, with many of those customers also owning a Mercedes-Benz, Bentley or Aston Martin.
Karma has 36 dealerships globally, including in the U.S., Canada, Europe and the Middle East.
The company's sales goal for 2025 — about 250 — is modest, but McCammon told Automotive News that the brand still intends to eventually reach annual deliveries of around 5,000.
'At that point, we're solid and profitable and we're able to innovate the way that we want,' McCammon said. 'For us to get to that stability is about half of that. We don't need to do a lot. We just need to do what we do well.'
Have an opinion about this story? Tell us about it and we may publish it in print. Click here to submit a letter to the editor.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Amazon's emissions climbed 6% in 2024 on data center buildout
Amazon's emissions climbed 6% in 2024 on data center buildout

Boston Globe

timean hour ago

  • Boston Globe

Amazon's emissions climbed 6% in 2024 on data center buildout

Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up TECH Advertisement Nvidia CEO downplays role in lifting US ban on chip sales to China CEO of Nvidia Jensen Huang spoke to journalists during a press conference at the Mandarin Oriental Qianmen after attending the third China International Supply Chain Expo, in Beijing, on Wednesday. Andy Wong/Associated Press The head of Nvidia downplayed his role in getting the US government to lift a ban on selling an advanced computer chip in China and said it will take time to ramp up production once orders for the AI-processor come in. CEO Jensen Huang, speaking Wednesday in the Chinese capital Beijing, was upbeat about the prospects for the H20 chip, which was designed to meet US restrictions on technology exports to China but nonetheless blocked in April. He met President Trump before his trip and his company announced this week it had received assurances that sales to China would be approved. 'I don't think I changed his mind,' Huang told a cluster of journalists, many of whom asked for his autograph or to take selfies with him. He described his role as informing governments in the United States and elsewhere of the nature and unintended consequences of their policies. The decision to lift the ban on the H20 chip was entirely in the hands of the American and Chinese governments and whatever trade talks they had, he said. 'We can only influence them, inform them, do our best to provide them with facts,' Huang said. 'And then beyond that is out of our control.' — ASSOCIATED PRESS Advertisement ECONOMY Fed Beige Book shows slight improvement People walk in a shopping district along 5th Avenue in Manhattan on July 14. Spencer Platt/Getty US economic activity 'increased slightly' between late May and early July, the Federal Reserve said in its Beige Book survey of regional business contacts. 'That represented an improvement over the previous report, in which half of districts reported at least slight declines in activity,' according to the report published Wednesday. 'Uncertainty remained elevated, contributing to ongoing caution by businesses.' All 12 regions of the country reported price increases, with businesses experiencing 'modest to pronounced input cost pressures related to tariffs,' the Beige Book said. 'Many firms passed on at least a portion of cost increases to consumers through price hikes or surcharges, although some held off raising prices because of customers' growing price sensitivity, resulting in compressed profit margins,' according to the report. The Boston Fed compiled the latest edition of the Beige Book using information gathered on or before July 7. The report includes commentary and anecdotes from business leaders and other contacts in each of the Fed's 12 regional districts. Fed officials next meet July 29-30. — BLOOMBERG NEWS Advertisement PHARMACEUTICALS J&J shrugs off Trump tariff threat and boosts outlook The Johnson & Johnson campus in New Brunswick, N.J. Mark Kauzlarich/Bloomberg Johnson & Johnson beat Wall Street's quarterly sales expectations and raised its full-year outlook, a show of confidence as the pharmaceutical industry faces the dual threats of tariffs and a crackdown on drug pricing. J&J's strong second quarter comes as President Trump floats the idea of levies on the sector. On Tuesday night, he said tariffs on drugs could 'probably' come at the end of the month, starting low and working their way up. A week earlier, Trump told reporters he would impose tariffs as high as 200 percent on drug companies if they don't shift more of their manufacturing to the US over the next year to 18 months. A slow ramp-up to tariffs would actually be good news, J&J chief financial officer Joe Wolk said in an interview. The delay shows 'there's an understanding you can't put up a biopharmaceutical manufacturing facility overnight,' Wolk said. 'As long as those conversations continue to occur, I think we're in a pretty good position.' Shares rose 6.2 percent in Wednesday trading. J&J is often an industry bellwether as the first heath care company to report earnings each quarter. Its performance is being closely watched as drugmakers operate under the specter of potential tariffs and a new policy that seeks to make US drug prices among the lowest in the world. — BLOOMBERG NEWS HEALTH Kennedy fires 2 top aides in department shake-up US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. a roundtable discussion on soil health at the US Capitol on July 15. Michael M. Santiago/Getty Health Secretary Robert F. Kennedy Jr. fired two of his top aides this week, shaking up his leadership team at the Department of Health and Human Services amid an aggressive effort to reshape public health policy. The firings were of Heather Flick Melanson, his chief of staff, and Hannah Anderson, his deputy chief of staff for policy, according to two people familiar with the matter. They spoke on the condition of anonymity because they were not authorized to speak publicly about the personnel changes. The reason for the ousters, which were first reported by CNN, was not immediately clear. Both Flick Melanson and Anderson were seen as steady and effective government veterans. During a recent Senate hearing, Kennedy indicated that they were the people in his office to call to get things done. When one lawmaker raised a concern about regulations governing the amount of sugar in orange juice, Kennedy advised: 'Why don't you call Heather Flick or Hannah Anderson this week? And we will act on that as quickly as we can.' But Kennedy has also demonstrated that he is willing to muscle his agenda forward. He has pushed ahead with a plan to fire about 20,000 staff members from the health department and pare down 28 divisions to 15 — all amid court challenges. — NEW YORK TIMES Advertisement

Faced with geopolitics and trade war, US companies in China report record-low new investment plans

time2 hours ago

Faced with geopolitics and trade war, US companies in China report record-low new investment plans

WASHINGTON -- American companies in China are reporting record-low new investment plans for this year and declining confidence in profits, while uncertainty in U.S.-China relations and President Donald Trump's tariffs have become their top concerns, according to a business survey released Wednesday. The companies are also challenged by China's slowing economy, where weak domestic demand and overcapacity in local industries are eroding profitability for the Americans. 'Businesses in China are less profitable now than they were years ago, but risks, including reputational risk, regulatory risk, and political risk, are increasing,' said Sean Stein, the president of the U.S.-China Business Council, a Washington-based group that represents American companies doing business in China, including major multinationals. The survey, conducted between March and May and drawing from 130 member companies, came after the two countries clashed over tariffs and nontariff measures, including export controls on critical products such as rare-earth magnets and advanced computer chips. Following high-level talks in Geneva and London, U.S. and Chinese officials agreed to pull back from sky-high tariffs and restrictions on exports, but uncertainty persists as the two sides are yet to hammer out a more permanent trade deal. Kyle Sullivan, vice president of business advisory services at the USCBC, said more than half of the companies in the survey indicated they do not have new investment plans in China 'at all' this year. "That's a record high,' Sullivan said, noting that it is 'a new development that we have not observed in previous surveys.' Around 40% of companies reported negative effects from U.S. export control measures, with many experiencing lost sales, severed customer relationships, and reputational damage from being unreliable suppliers, according to the survey. Citing national security, the U.S. government has banned exports to China of high-tech products, such as the most advanced chips, which could help boost China's military capabilities. Stein argued that export controls must be very carefully targeted, because businesses from Europe or Japan, or local businesses in China would immediately fill the void left by American companies. Silicon Valley chipmaker Nvidia won approval from the Trump administration to resume sales to China of its advanced H20 chips used to develop artificial intelligence, its CEO Jensen Huang announced on Monday, though the company's most powerful chips remain under U.S. export control rules. While 82% of U.S. companies reported profits in 2024, fewer than half are optimistic about the future in China, reflecting concerns over tariffs, deflation, and policy uncertainty, according to the survey. Also, a record high number of American businesses plan to relocate their business operations outside of China, Sullivan said, as 27% of the members indicated so, up from 19% the year before. In a departure from past surveys, concerns over China's regulatory environment, including risks of intellectual property misuse and lack of market access, didn't make it to the top five concerns this year. That's likely a first, and not for a good reason, Stein said. 'It is not because things got dramatically better on the Chinese side, but the new challenges, often coming from the U.S., are now posing as much of a challenge,' Stein said. Almost all the American companies said they cannot remain globally competitive without their Chinese operations. A survey from the European Union Chamber of Commerce in China in May found that European companies were cutting costs and scaling back investment plans in China as its economy slows and fierce competition drives down prices.

EU Exports to U.S. Cool as Trans-Atlantic Trade Faces Tariff Test
EU Exports to U.S. Cool as Trans-Atlantic Trade Faces Tariff Test

Yahoo

time2 hours ago

  • Yahoo

EU Exports to U.S. Cool as Trans-Atlantic Trade Faces Tariff Test

Europe's exports to the U.S. fell for the second consecutive month in May after a first-quarter boom, but remained higher than a year earlier, a sign of resilience that will be tested as higher tariffs look set to become a settled feature of trans-Atlantic trade. Exports to the U.S. from the European Union edged down to 46.2 billion euros, or around $53.6 billion, in May from 47.6 billion euros a month earlier, statistics agency Eurostat said Wednesday. Overall exports fell 0.8%, with the EU's overall trade surplus rising to 13.4 billion euros. Forget TACO. Trump Is Winning His Trade War. Trump Executive Order to Help Open Up 401(k)s to Private Markets Trump Effect Starts to Show Up in Economy Inflation Picks Up to 2.7% as Tariffs Start to Seep Into Prices Dimon Defends Fed Independence After Trump Attacks The EU's exports to the U.S. fell sharply in April after reaching a record high in March, when American importers stockpiled goods ahead of the Trump administration's impending tariff announcements. The U.S. and EU have been in talks over a trade agreement for months. President Trump in May threatened to jack up so-called reciprocal tariffs on EU goods of 50%, blaming the slow progress of trade talks, before backing down to allow negotiations to continue. Then Trump on Saturday said he would raise tariffs on most goods from the EU to 30% on Aug. 1. Goods are currently subject to a 10% baseline tariff, with car-parts and some metals subject to higher taxes. A 30% levy would strike at the core of Germany's export economy, Chancellor Friedrich Merz told German broadcaster ARD on Sunday. The U.S. last year overtook China as Germany's main trade partner, accounting for more than 250 billion euros in both exports and imports. Now trade barriers have seen Chinese goods being redirected to Europe and away from the American market. China's exports to the EU rose 7.6% on year in June, but exports to the U.S. sank 16%, according to official data published Monday. The EU's trade commissioner Maros Sefcovic said Monday that 30% tariffs would make it almost impossible to continue the current level of trade between the bloc and the U.S. 'Practically it prohibits trade,' he told reporters. 'Trading as we know it will not continue, with huge negative effects on both sides of the Atlantic.' Trump's tariff threats are already rattling some European manufacturers. ASML Holding, the Dutch chip-making equipment supplier and one of Europe's largest companies by market cap, said it could no longer guarantee growth in 2026 amid the uncertainty. Shares in Amsterdam sank in Wednesday morning trading. The U.S.-EU relationship accounts for about 30% of global goods trade, according to the European Council. The EU has threatened tariffs on 72 billion euros of U.S. goods including cars, planes and whiskey, should talks collapse. The uncertainty has already prompted the European Central Bank to publish forecasts that say the eurozone economy would grow significantly slower in a scenario in which the U.S. imposed even higher tariffs and the EU retaliated. Demand for Europe's goods is also being damped by the appreciation of the euro against the dollar, which makes products more expensive for importers. Much of Europe's economic growth in the early part of the year came from front-loading of exports. Some of that continues: eurozone non-durable goods production, which includes pharmaceuticals, rose in May at its fastest pace since records began in 1991. But Trump on Tuesday floated tariffs by the end of July on pharmaceuticals, which have yet to be subject to levies. The threat is particularly acute in some nations. Ireland's hosting of major medicine manufacturers means around one-third of its total exports went to the U.S. last year. Write to Ed Frankl at Tesla's Top North American Sales Executive Leaves Amid Slump 'Trump Accounts' for Kids Come With $1,000—and Tax Complications BlackRock Shares Tumble After Big Client Redemption Blunts Quarterly Results Aquarian Nears Deal for U.S. Insurer Brighthouse New Inflation Figures Sober Stock and Bond Markets Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store